Page 105 - Oncology Coder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oncology coder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oncology Coder Today - Breaking & Trending Today

Implementing Trial Data to Our Practice

Stephanie Graff, MD, and Rachel Layman, MD, discuss how they would apply the results of the monarchE trial to clinical case scenarios. ....

Stephanie Graff , Treatment Approach , Breast Cancer , Trial Data , Rachel Layman , High Risk , Node Positive , Pre Menopausal , Post Menopausal , Cdk4 6 Inhibitors ,

Fruquintinib significantly improves survival in patients with refractory metastatic colorectal cancer

1. Overall survival was significantly greater in the fruquintinib group versus placebo. 2. The majority of adverse events were mild-to-moderate and were slightly more common among patients receiving fruquintinib. Evidence Rating Level: 1 (Excellent) Study Rundown: Colorectal cancer is the third-most prevalent cancer in the world and the second leading cause of death worldwide. Patients ....

Rating Level , Colonoscopy Screening , Colorectal Cancer , Between Aug , Colon Cancer , Metastatic Colorectal Cancer , Vegf Inhibitors , Chronic Disease ,

Dr Susan Escudier Talks Barriers in Oncology Specialist, PCP Collaboration

The biggest barriers in collaboration are communication and connectivity, said Susan Escudier, MD, FACP, vice president of value-based and quality programs for Texas Oncology. ....

United States , Susan Escudier , Texas Oncology , Blue Cross Shield ,